Idi na sadržaj

RAR-alfa

S Wikipedije, slobodne enciklopedije
RAR-alfa
Dostupne strukture
PDBPretraga ortologa: PDBe RCSB
Spisak PDB ID kodova

1DKF, 1DSZ, 3A9E, 3KMR, 3KMZ, 4DQM, 5K13

Identifikatori
AliasiRARA
Vanjski ID-jeviOMIM: 180240 MGI: 97856 HomoloGene: 20262 GeneCards: RARA
Lokacija gena (čovjek)
Hromosom 17 (čovjek)
Hrom.Hromosom 17 (čovjek)[1]
Hromosom 17 (čovjek)
Genomska lokacija za RAR-alfa
Genomska lokacija za RAR-alfa
Bend17q21.2Početak40,309,180 bp[1]
Kraj40,357,643 bp[1]
Lokacija gena (miš)
Hromosom 11 (miš)
Hrom.Hromosom 11 (miš)[2]
Hromosom 11 (miš)
Genomska lokacija za RAR-alfa
Genomska lokacija za RAR-alfa
Bend11 D|11 62.76 cMPočetak98,818,644 bp[2]
Kraj98,865,768 bp[2]
Obrazac RNK ekspresije




Više referentnih podataka o ekspresiji
Ontologija gena
Molekularna funkcija• retinoic acid binding
• GO:0001106 transcription corepressor activity
• protein domain specific binding
• GO:0001131, GO:0001151, GO:0001130, GO:0001204 DNA-binding transcription factor activity
• GO:0038050, GO:0004886, GO:0038051 nuclear receptor activity
• mRNA 5'-UTR binding
• signaling receptor binding
• RNA polymerase II transcription regulatory region sequence-specific DNA binding
• retinoic acid-responsive element binding
• transcription factor binding
• vezivanje iona metala
• steroid hormone receptor activity
• vezivanje enzima
• vezivanje iona cinka
• GO:0001948, GO:0016582 vezivanje za proteine
• vezivanje sa DNK
• sequence-specific DNA binding
• GO:0001105 transcription coactivator activity
• protein kinase A binding
• protein kinase B binding
• translation repressor activity, mRNA regulatory element binding
• alpha-actinin binding
• protein heterodimerization activity
• chromatin DNA binding
• GO:0001200, GO:0001133, GO:0001201 DNA-binding transcription factor activity, RNA polymerase II-specific
• histone deacetylase binding
• GO:0000975 transcription cis-regulatory region binding
• nuclear receptor coactivator activity
• signaling receptor activity
Ćelijska komponenta• citoplazma
• actin cytoskeleton
• perinuklearno područje citoplazme
• neuron projection
• jedro
• cell surface
• nukleoplazma
• soma
• dendrit
• citosol
• RNA polymerase II transcription regulator complex
Biološki proces• growth plate cartilage development
• germ cell development
• cellular response to retinoic acid
• ureteric bud development
• positive regulation of interleukin-5 production
• prostate gland development
• limb development
• apoptotic cell clearance
• chondroblast differentiation
• regulation of granulocyte differentiation
• protein phosphorylation
• response to vitamin A
• face development
• Spermatogeneza
• response to ethanol
• negative regulation of cell population proliferation
• steroid hormone mediated signaling pathway
• regulation of apoptotic process
• response to cytokine
• negative regulation of translation
• GO:0009373 regulation of transcription, DNA-templated
• negative regulation of cell differentiation
• negative regulation of gene expression
• transcription, DNA-templated
• cellular response to estrogen stimulus
• GO:0060469, GO:0009371 positive regulation of transcription, DNA-templated
• positive regulation of cell cycle
• regulation of myelination
• positive regulation of neuron differentiation
• negative regulation of tumor necrosis factor production
• transcription initiation from RNA polymerase II promoter
• trachea cartilage development
• glandular epithelial cell development
• male gonad development
• negative regulation of cartilage development
• response to retinoic acid
• negative regulation of granulocyte differentiation
• multicellular organism growth
• female pregnancy
• negative regulation of apoptotic process
• GO:1901227 negative regulation of transcription by RNA polymerase II
• positive regulation of interleukin-4 production
• regulation of synaptic plasticity
• outflow tract septum morphogenesis
• GO:0045996 negative regulation of transcription, DNA-templated
• negative regulation of interferon-gamma production
• response to estradiol
• negative regulation of translational initiation
• embryonic camera-type eye development
• positive regulation of interleukin-13 production
• neural tube closure
• positive regulation of binding
• retinoic acid receptor signaling pathway
• GO:1901313 positive regulation of gene expression
• Sertoli cell fate commitment
• positive regulation of cell population proliferation
• positive regulation of T-helper 2 cell differentiation
• ventricular cardiac muscle cell differentiation
• liver development
• cellular response to lipopolysaccharide
• bone development
• hippocampus development
• GO:0072468 Transdukcija signala
• GO:0003257, GO:0010735, GO:1901228, GO:1900622, GO:1904488 positive regulation of transcription by RNA polymerase II
• multicellular organism development
• hormone-mediated signaling pathway
• Ćelijska diferencijacija
• response to lipid
• gland development
• bone morphogenesis
• epithelium development
Izvori:Amigo / QuickGO
Ortolozi
VrsteČovjekMiš
Entrez
Ensembl
UniProt
RefSeq (mRNK)

NM_000964
NM_001024809
NM_001033603
NM_001145301
NM_001145302

NM_001176528
NM_001177302
NM_001177303
NM_009024
NM_001361954

RefSeq (bjelančevina)
NP_000955
NP_001019980
NP_001138773
NP_001138774
NP_000955.1

NP_001138773.1

NP_001169999
NP_001170773
NP_001170774
NP_033050
NP_001348883

Lokacija (UCSC)Chr 17: 40.31 – 40.36 MbChr 11: 98.82 – 98.87 Mb
PubMed pretraga[3][4]
Wikipodaci
Pogledaj/uredi – čovjekPogledaj/uredi – miš

Receptor alfa retinojske kiseline (RAR-α), znan i kao NR1B1 (član 1 grupe B potporodice 1 jedarnih receptora) jest jedarni receptorski protein koji je kod ljudi kodiran genom RARA sa hromosoma 17.[5][6]

NR1B1 je gen sa proteinskim proizvodom i ima hromosomsku lokaciju 17q21.2. RARA kodira receptora jedarnog hormona, receptor retinojske kiseline, podtip alfa i sam je transkripcijski faktor. Postoje još dva podtipa RAR-a, beta i gama.[7][8]

Aminokiselinska sekvenca

[uredi | uredi izvor]

Dužina polipeptidnog lanca je 462 aminokiseline, a molekulska težina 50.771 Da.

1020304050
MASNSSSCPTPGGGHLNGYPVPPYAFFFPPMLGGLSPPGALTTLQHQLPV
SGYSTPSPATIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHY
GVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFE
VGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFP
ALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFT
TLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNA
GFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDM
LQEPLLEALKVYVRKRRPSRPHMFPKMLMKITDLRSISAKGAERVITLKM
EIPGSMPPLIQEMLENSEGLDTLSGQPGGGGRDGGGLAPPPGSCSPSLSP
SSNRSSPATHSP

Funkcija

[uredi | uredi izvor]

Retinoidnu signalizaciju transduciraju članovi dvije porodice jedarnih receptora, receptor retinojske kiseline (RAR) i retinoidnui X-receptor (RXR), koji formiraju RXR/RAR heterodimere. U nedostatku liganda, DNK vezani RXR/RARA potiskuje transkripciju, regrutacijom korepresora NCOR1, SMRT (NCOR2), i histon-deacetilaze. Kada se ligand veže za kompleks, inducira konformacijsku promjenu koja omogućava regrutovanje koaktivatora, histon-acetiltransferaza i osnovnog transkripcijskog mehanizma.[9]

Receptor retinoične kiseline alfa, protein, stupa u interakciju sa retinojskom kiselinom, derivatom vitamina A, koji ima važnu ulogu u rastu ćelija, diferencijaciji i formiranju organa u razvoju embriona.[8][10]

Kada se retinoična kiselina veže za RAR, oni pokreću transkripciju i omogućavaju ekspresiju njihovog gena.[10]

Klinički značaj

[uredi | uredi izvor]

RA signalizacija je u korelacijama sa nekoliko signalnih puteva u ranom embrionskom razvoju. Prvo, učestvuje u formiranju embrionske osovine, koja uspostavlja simetriju u potomstvu. RA također utiče na nervnu diferencijaciju. regulacijom ekspresije proneurvnog indukcionog faktora meurogenina 2 (neurog2). RA utiče na kardiogenezu, jer ima posebnu ulogu u formiranju srčane pretkomore. RA također ima ulogu u razvoju pankreasa, bubrega, pluća i ekstremiteta.[10]

Translokacije koje uvijek uključuju preuređivanje gena RARA su kardinalna karakteristika akutne promijelocitne leukemije (APL; MIM 612376). Najčešća translokacija je t(15,17)(q21;q22), koja spaja gen RARA sa genom PML.[11]

Interakcije

[uredi | uredi izvor]

Pokazalo se da receptor alfa retinojske kiseline reaguje sa:

Genetic Studies

[uredi | uredi izvor]

Knock-out mice studies showed that a deletion in one of the copies of the RARA gene did not create any observable defect, while deletion of both copies shoes symptoms similar to that of Vitamin A deficiency. This proved that all 3 subtypes of RARs work redundantly.

See also

[uredi | uredi izvor]

Reference

[uredi | uredi izvor]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000131759 - Ensembl, maj 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000037992 - Ensembl, maj 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ↑ Giguere V, Ong ES, Segui P, Evans RM (1987). "Identification of a receptor for the morphogen retinoic acid". Nature. 330 (6149): 624–9. Bibcode:1987Natur.330..624G. doi:10.1038/330624a0. PMID 2825036. S2CID 4308015.
  6. ↑ Anderson LA, Friedman L, Osborne-Lawrence S, Lynch E, Weissenbach J, Bowcock A, King MC (septembar 1993). "High-density genetic map of the BRCA1 region of chromosome 17q12-q21". Genomics. 17 (3): 618–23. doi:10.1006/geno.1993.1381. PMID 8244378.
  7. ↑ "Gene symbol report | HUGO Gene Nomenclature Committee". www.genenames.org. Pristupljeno 27. 4. 2021.
  8. 1 2 "OMIM Entry - * 180240 - RETINOIC ACID RECEPTOR, ALPHA; RARA". www.omim.org. Pristupljeno 27. 4. 2021.
  9. ↑ "Entrez Gene: retinoic acid receptor". Arhivirano s originala, 10. 3. 2022. Pristupljeno 10. 3. 2022.
  10. 1 2 3 Kam RK, Deng Y, Chen Y, Zhao H (mart 2012). "Retinoic acid synthesis and functions in early embryonic development". Cell & Bioscience. 2 (1): 11. doi:10.1186/2045-3701-2-11. PMC 3325842. PMID 22439772.
  11. ↑ Vitoux D, Nasr R, de The H (2007). "Acute promyelocytic leukemia: new issues on pathogenesis and treatment response". The International Journal of Biochemistry & Cell Biology. 39 (6): 1063–70. doi:10.1016/j.biocel.2007.01.028. PMID 17468032.
  12. ↑ Liu R, Takayama S, Zheng Y, Froesch B, Chen GQ, Zhang X, et al. (juli 1998). "Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells". The Journal of Biological Chemistry. 273 (27): 16985–92. doi:10.1074/jbc.273.27.16985. PMID 9642262.
  13. 1 2 McNamara P, Seo SB, Rudic RD, Sehgal A, Chakravarti D, FitzGerald GA (juni 2001). "Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock". Cell. 105 (7): 877–89. doi:10.1016/S0092-8674(01)00401-9. PMID 11439184. S2CID 6251321.
  14. ↑ Despouy G, Bastie JN, Deshaies S, Balitrand N, Mazharian A, Rochette-Egly C, et al. (februar 2003). "Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II". The Journal of Biological Chemistry. 278 (8): 6355–62. doi:10.1074/jbc.M210697200. PMID 12482873.
  15. ↑ Lee SK, Jung SY, Kim YS, Na SY, Lee YC, Lee JW (februar 2001). "Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2". Molecular Endocrinology. 15 (2): 241–54. doi:10.1210/me.15.2.241. PMID 11158331.
  16. ↑ Lee SK, Anzick SL, Choi JE, Bubendorf L, Guan XY, Jung YK, et al. (novembar 1999). "A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo". The Journal of Biological Chemistry. 274 (48): 34283–93. doi:10.1074/jbc.274.48.34283. PMID 10567404.
  17. ↑ Ko L, Cardona GR, Chin WW (maj 2000). "Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator". Proceedings of the National Academy of Sciences of the United States of America. 97 (11): 6212–7. Bibcode:2000PNAS...97.6212K. doi:10.1073/pnas.97.11.6212. PMC 18584. PMID 10823961.
  18. ↑ Dowell P, Ishmael JE, Avram D, Peterson VJ, Nevrivy DJ, Leid M (maj 1999). "Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein". The Journal of Biological Chemistry. 274 (22): 15901–7. doi:10.1074/jbc.274.22.15901. PMID 10336495.
  19. ↑ Guidez F, Ivins S, Zhu J, Söderström M, Waxman S, Zelent A (april 1998). "Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia". Blood. 91 (8): 2634–42. doi:10.1182/blood.V91.8.2634.2634_2634_2642. PMID 9531570.
  20. ↑ Dong S, Tweardy DJ (april 2002). "Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways". Blood. 99 (8): 2637–46. doi:10.1182/blood.V99.8.2637. PMID 11929748.
  21. ↑ Hong SH, David G, Wong CW, Dejean A, Privalsky ML (august 1997). "SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia". Proceedings of the National Academy of Sciences of the United States of America. 94 (17): 9028–33. Bibcode:1997PNAS...94.9028H. doi:10.1073/pnas.94.17.9028. PMC 23013. PMID 9256429.
  22. ↑ Hu X, Chen Y, Farooqui M, Thomas MC, Chiang CM, Wei LN (januar 2004). "Suppressive effect of receptor-interacting protein 140 on coregulator binding to retinoic acid receptor complexes, histone-modifying enzyme activity, and gene activation". The Journal of Biological Chemistry. 279 (1): 319–25. doi:10.1074/jbc.M307621200. PMID 14581481.
  23. ↑ Farooqui M, Franco PJ, Thompson J, Kagechika H, Chandraratna RA, Banaszak L, Wei LN (februar 2003). "Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity". Biochemistry. 42 (4): 971–9. doi:10.1021/bi020497k. PMID 12549917.
  24. ↑ L'Horset F, Dauvois S, Heery DM, Cavaillès V, Parker MG (novembar 1996). "RIP-140 interacts with multiple nuclear receptors by means of two distinct sites". Molecular and Cellular Biology. 16 (11): 6029–36. doi:10.1128/MCB.16.11.6029. PMC 231605. PMID 8887632.
  25. ↑ Seol W, Choi HS, Moore DD (maj 1996). "An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors". Science. 272 (5266): 1336–9. Bibcode:1996Sci...272.1336S. doi:10.1126/science.272.5266.1336. PMID 8650544. S2CID 32853062.
  26. ↑ Seol W, Hanstein B, Brown M, Moore DD (oktobar 1998). "Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner)". Molecular Endocrinology. 12 (10): 1551–7. doi:10.1210/me.12.10.1551. PMID 9773978.
  27. ↑ Perlmann T, Jansson L (april 1995). "A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1". Genes & Development. 9 (7): 769–82. doi:10.1101/gad.9.7.769. PMID 7705655.
  28. ↑ Zhong S, Delva L, Rachez C, Cenciarelli C, Gandini D, Zhang H, et al. (novembar 1999). "A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins". Nature Genetics. 23 (3): 287–95. doi:10.1038/15463. PMID 10610177. S2CID 23613492.
  29. ↑ Benkoussa M, Brand C, Delmotte MH, Formstecher P, Lefebvre P (juli 2002). "Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter". Molecular and Cellular Biology. 22 (13): 4522–34. doi:10.1128/MCB.22.13.4522-4534.2002. PMC 133906. PMID 12052862.
  30. ↑ Bugge TH, Pohl J, Lonnoy O, Stunnenberg HG (april 1992). "RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors". The EMBO Journal. 11 (4): 1409–18. doi:10.1002/j.1460-2075.1992.tb05186.x. PMC 556590. PMID 1314167.
  31. ↑ Kim HJ, Yi JY, Sung HS, Moore DD, Jhun BH, Lee YC, Lee JW (septembar 1999). "Activating signal cointegrator 1, a novel transcription coactivator of nuclear receptors, and its cytosolic localization under conditions of serum deprivation". Molecular and Cellular Biology. 19 (9): 6323–32. doi:10.1128/mcb.19.9.6323. PMC 84603. PMID 10454579.
  32. ↑ He B, Wilson EM (mart 2003). "Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs". Molecular and Cellular Biology. 23 (6): 2135–50. doi:10.1128/MCB.23.6.2135-2150.2003. PMC 149467. PMID 12612084.
  33. ↑ Zeng M, Kumar A, Meng G, Gao Q, Dimri G, Wazer D, et al. (novembar 2002). "Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator". The Journal of Biological Chemistry. 277 (47): 45611–8. doi:10.1074/jbc.M208447200. PMID 12235159.
  34. ↑ Martin PJ, Delmotte MH, Formstecher P, Lefebvre P (septembar 2003). "PLZF is a negative regulator of retinoic acid receptor transcriptional activity". Nuclear Receptor. 1 (1): 6. doi:10.1186/1478-1336-1-6. PMC 212040. PMID 14521715.

Dopunska literatura

[uredi | uredi izvor]

Vanjski linkovi

[uredi | uredi izvor]

Šablon:Modulatori retinoidnog receptora Ovaj članak uključuje tekst iz Nacionalne medicinske biblioteke Sjedinjenih Država, koji je u javnom vlasništvu.